| August 1 |
Lux Presents Data at ARVO on LX214 as Potential Treatment for Dry Eye |
| August 1 |
Lab Study Shows Methadone Breaks Resistance in Untreatable Forms of Leukemia |
| August 1 |
MDRNA, Inc. Demonstrates In Vivo Efficacy with Proprietary DiLA2 Delivery Platform |
| August 1 |
Immunotherapy in High-Risk Pediatric Sarcomas Shows Promising Response |
| August 1 |
MDRNA Announces Phase 2 Trial of PYY(3-36) Does not Meet Weight Loss Endpoint |
| August 1 |
A Long Lasting Impression: New Study Find Persistent Brain Changes in Response to Cocaine Depend on the Expectation of Reward NIDA |
| August 1 |
Preclinical Data for a Topical Formulation of Voclosporin as a Potential Best-in-Class Treatment for Chronic Inflammatory Eye Diseases Presented at ARVO |
| August 4 |
Karo Bio Announces Successful Phase II Study with Eprotirome in Combination with Statin |
| August 4 |
Suven Life Sciences Presents Positive Preclinical Data for SUVN-502 at Alzheimer's Conference, Chicago and Drug Discovery Conference, Boston |
| August 4 |
Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease |
| August 4 |
Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients |
| August 4 |
HIV Treatment Widely-Used in Developing Countries May Be Less Effective When Used With Anti-TB Therapy |
| August 4 |
Growth Hormone Treatment for HIV-Related Abdominal Obesity Improves Abdominal Fat and Other Cardiovascular Measures, but May Be Limited By Effects on Glucose |
| August 4 |
Highly Active Antiretroviral Therapy of Similar Benefit for HIV-Infected Injection Drug Users |
| August 4 |
Turned-Off Cannabinoid Receptor Turns on Colorectal Tumor Growth |
| August 4 |
New Long-Term Prospective Study of Statin Drugs Confirms Utility To Reduce Risk of Dementia and Memory Loss |
| August 4 |
New Research Results Explain How Dormant Tumor Cells Become Active in Later Years |
| August 4 |
Leukemia Journal Publishes Results from Darinaparsin Study |
| August 4 |
Theratechnologies Reports on Positive Body Image Parameters at the International AIDS Conference |
| August 5 |
YM BioSciences Reports Phase II Data for Nimotuzumab Metastatic Colorectal Cancer |
| August 5 |
Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C |
| August 5 |
Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845 |
| August 5 |
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding |
| August 5 |
Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences |
| August 5 |
Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years |
| August 5 |
Urologists Should Recognize the Cardiac Safety of Prescribed Medications, Article Concludes |
| August 5 |
Treatment With Anti-Anemia Drugs May Not Be Safe For Multiple Myeloma Patients |
| August 5 |
MIV Announces Excellent Safety and Efficacy of VESTAsync Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up |
| August 5 |
YM Biosciences Conference Call to Discuss Phase II Data for Nimotuzumab in Metastic Colorectal Cancer |
| August 5 |
CASTLE Data Showed Boosted Reyataz (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender |
| August 5 |
Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 |
| August 5 |
Isentress (raltegravir), Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell Counts Through 96 Weeks in Treatment-Naive HIV-Infected Patients When Taken With Other Anti-HIV Medicines |
| August 5 |
Abbott's Kaletra Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines |
| August 5 |
Stanford Study Finds HIV Drug Can Persist in Mothers' Milk, Increasing Risk to Them and Their Babies |
| August 6 |
CASTLE Data Showed Boosted Reyataz (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender |
| August 6 |
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV) Met its Primary Endpoint |
| August 6 |
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant |
| August 6 |
Inspire Announces Peer-Reviewed Publications Related to Denufosol for Cystic Fibrosis |
| August 6 |
Protherics Plc DEEP Results in Pre-Eclampsia to be Presented at Leading Conference |
| August 6 |
Cortex's AMPAKINE Molecule CX717 Has Positive Effects in Opiate-Induced Respiratory Depression in a Phase IIa Clinical Study |
| August 6 |
Mesoblast Limited (ASX:MSB); Non-healing Bones Repaired II Clinical Trial Using Adult Stem Cells |
| August 6 |
Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule |
| August 6 |
Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy |
| August 6 |
Genetic Biomarker Linked to Subcutaneous Growth Hormone Dose-Response |
| August 6 |
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease |
| August 7 |
Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study |
| August 7 |
Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling |
| August 7 |
New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers |
| August 7 |
New Prostate Cancer Test is Ready for Commercialization Following Successful Completion of Final Clinical Trials |
| August 7 |
Argos Therapeutics' Arcelis Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial |
| August 7 |
Mesoblast Limited (ASX:MSB) National Media Coverage Focused on Results of Adult Stem Cell Bone Repair Trial |
| August 7 |
IMPAX Reports Positive Results in Phase III Trial with IPX056 |
| August 7 |
Head-to-Head 96-Week Study Shows Epizcom is Comparable to Truvada in Efficacy and Safety Measures in HIV Treatment-Naive Patients |
| August 7 |
Analysis of Six Clinical Trials Finds Epzicom Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads |
| August 7 |
Macular Degeneration Risk Studied in an Asian Population; Time Spent Outdoors Impacts Nearsightedness in Children; and Two Treatments to Combat Ocular Surface Cancer |
| August 7 |
Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference |
| August 8 |
Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule |
| August 8 |
Santhera Provides Update on Clinical/Regulatory Processes with SNT-MC17/Idebenone for the Treatment of Friedreich's Ataxia |
| August 11 |
NanoViricides, Inc. Reports that HIVCide-I Was Significantly Superior to the Current Anti-HIV Three Drug Cocktail Standard |
| August 11 |
Altus Pharmaceuticals Announces Achievement of Primary Endpoint in Phase 3 Efficacy Trial of Trizytek for Cystic Fibrosis Patients with Pancreatic Insufficiency |
| August 12 |
Alnylam and Collaborators Publish New Preclinical Research on RNAi-Mediated Silencing of PCSK9 |
| August 12 |
Losing Weight After Diabetes Diagnosis can Prevent Diabetes-Related Disease, Kaiser Permanente Study Finds |
| August 12 |
Dicerna Pharmaceuticals' Co-founders Publish Studies Describing Novel Approaches to Maximizing Dicer-Substrate Small Interfering RNAs (DsiRNAs) |
| August 12 |
Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting |
| August 12 |
VitiGam Inhibits Melanoma Growth in a Dose Dependent Manner |
| August 12 |
Bronchitol Cystic Fibrosis Dose Trial Results Positive |
| August 12 |
Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic |
| August 12 |
Mesoblast Limited Stem Cells Regrow Knee Cartilage in Severe Post-Menopausal Osteoarthritis |
| August 12 |
Cholesterol Drug Plays Role in Melanoma Remission |
| August 12 |
Experimental Chemotherapy Regimen Shows Promise in Treating Advanced Lung Cancer |
| August 12 |
Risk Assessment Plays Key Role in Long-Term Treatment of Breast Cancer |
| August 13 |
NewCardio Announces Positive Results From Third Clinical Validation Study |
| August 13 |
MDRNA, Inc. Lead Candidate Demonstrates In Vivo Efficacy against Seasonal and Pandemic Flu Strains |
| August 13 |
Nasal Hepatitis B Vaccine Elicits Robust Immunity With a Single Dose; Confers Major Advantages Over Traditional Vaccines |
| August 13 |
Obesity, Previous Use of HRT, and Treatment with Aromatase Inhibitors Puts Postmenopausal Women with Early-Stage Breast Cancer at Increased Risk of Joint Symptoms |
| August 13 |
NIH Scientists Find a Novel Mechanism that Controls the Development of Autoimmunity |
| August 13 |
i3 Drug Safety to Deliver 17 Presentations at ICPE 2008 |
| August 14 |
Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure |
| August 14 |
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 |
| August 14 |
Probiodrug to Present Potential New Treatment for Alzheimer’s Disease |
| August 14 |
New Study Highlights Importance for Women to Know Their Risk of Heart Disease |
| August 14 |
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 |
| August 14 |
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN) |
| August 14 |
'Protein Complementarity' May Offer New Insights Into Autoimmune Diseases |
| August 14 |
Micromet Data Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab |
| August 14 |
Researchers Find Leishmaniasis Parasites Evade Death by Exploiting the Immune Response to Sand Fly Bites |
| August 15 |
Antisoma plc: Evidence of Activity Seen in New Data from ASA404 Prostate Cancer Trial |
| August 15 |
Alternative Vaccine Strategy Shows Promise in Prostate Cancer Patients |
| August 15 |
Treatment with Plerixafor Shown to Improve Mobilization of Cells in Donors During Bone Marrow Stem Cell Collection Procedures |
| August 15 |
Giving Heart Attack Patients Anticlotting Drug Tirofiban in Ambulance Improves Clinical Outcome in Hospital (On-TIME 2 Study) |
| August 15 |
Combination Therapy Reduces Proteinuria More Than Single Drugs but causes More Kidney Damage (ONTARGET STUDY) |
| August 18 |
Repros Therapeutics Inc. Provides Update for US Phase II Endometriosis Study and Completion of QT Interval Dose Selection Screen |
| August 18 |
Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE |
| August 18 |
Dyax Announces DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA4(R)) |
| August 18 |
Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug |
| August 18 |
Prescription Sleeping Pill Use Tied to Cancer |
| August 18 |
Use of Conventional Antipsychotics Medications Linked to Increased Risk of Cardiovascular, Respiratory Disease Deaths in Elderly Patients |
| August 19 |
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration |
| August 19 |
Afid Therapeutics Inc.'s New Anticoagulant Heparin Replacement Passes in Vivo Test |
| August 19 |
Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors |
| August 19 |
Pain Therapeutics and King Pharmaceuticals Announce Final Data of Remoxy Phase III Study at World Pain Congress in Scotland |
| August 19 |
Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome |
| August 19 |
New Data Show Prolonged Release Oxycodone/Naloxone Provides Effective Pain Relief and Reduces OIC in Patients with Severe Chronic Pain |
| August 19 |
Hayes Evaluates Test and Treatment Options for Attention-Deficit Hyperactivity Disorder |
| August 19 |
Bacterial Pneumonia Caused Most Deaths in 1918 Influenza Pandemic Implications for Future Pandemic Planning |
| August 19 |
Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at Prestigious IHV Meeting |
| August 19 |
Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells |
| August 20 |
12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis |
| August 20 |
Positive Findings Published on Emergent Technology for Treating Chronic Pain |
| August 20 |
TheraQuest Presents Topical Local Anesthetic and Abuse Deterrence Data at the World Congress on Pain |
| August 21 |
Vaxfectin-formulated Measles DNA Vaccine Could Address Unmet Need for Infants |
| August 21 |
Repros Therapeutics Inc. Announces No Tumors in First Completed Proellex Animal Carcinogenicity Study |
| August 21 |
PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet |
| August 21 |
Metvix Prevents Pre-cancerous Lesions in Transplant Patients |
| August 21 |
Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events |
| August 21 |
Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008 |
| August 21 |
Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss |
| August 21 |
Javelin Presents Successful Pivotal Phase 3 Secondary Clinical Results for Dyloject at the 12th World Congress on Pain |
| August 21 |
Kamada Successfully Completes Phase II Trial with Aerosolized AAT in Cystic Fibrosis Patients |
| August 21 |
VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study |
| August 21 |
New Drug for Cystic Fibrosis Bypasses Genetic Defect and Improves Cell Membrane Function |
| August 22 |
ARYx Therapeutics, Inc. Announces Successful Results of Chronic Constipation Clinical Trial on ATI-7505 |
| August 22 |
Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone |
| August 22 |
Synta Announces Publication of Elesclomol Mechanism of Action Results in AACR Journal Molecular Cancer Therapeutics |
| August 22 |
Mesoblast Limited's (ASX:MSB) Allogeneic, "Off-The-Shelf", Stem Cells Are Safe And Effective For Cervical Spine Fusion |
| August 25 |
Patients Taking Cymbalta Experienced Reduced Chronic Low Back Pain in New Study |
| August 25 |
Extensively Drug-resistant Tuberculosis Can be Managed with Aggressive Treatment Strategy |
| August 25 |
NicOx Provides Update on PF-03187207 and the Ongoing Research Collaboration with Pfizer |
| August 25 |
Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics |
| August 25 |
Role of pramipexole in key research areas of Parkinson’s disease management discussed at 12th EFNS Congress |
| August 26 |
ADAGIO Trial Results Show Teva's Azilect 1 mg Tablets Slow Progression of Parkinson's Disease |
| August 26 |
More Evidence Published That Epidemics of Childhood Obesity, Type 2 Diabetes and Metabolic Syndrome are Linked to Immunization |
| August 26 |
Infections Linked to Premature Births More Common Than Thought, Stanford Study Finds |
| August 26 |
NeuroDiscovery Ltd: NSL-101 Demonstrates Effective Pain Relief in Phase IIa Trial |
| August 26 |
Pharmalink Reports Positive Phase III Results for Xepol, a Treatment for Post-Polio Syndrome |
| August 26 |
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program |
| August 26 |
XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention |
| August 26 |
Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery |
| August 26 |
Pramipexole Clinical Trial Programme in Restless Legs Syndrome (RLS) Reveals New Significant Results |
| August 26 |
New Publication Shows Cleviprex is Safe and Effective for Treatment of Acute, Severe Hypertension |
| August 26 |
Professor John F. Thompson to Present at Perspectives in Melanoma XII, Thursday October 2, 2008 |
| August 26 |
Early Trigger for Type-1 Diabetes Found in Mice, Stanford Scientists Report |
| August 26 |
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology |
| August 26 |
SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines |
| August 26 |
Individuals With History of Nonmelanoma Skin Cancer at Greater Risk for Future Cancers |
| August 27 |
Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program |
| August 27 |
Ark’s Vitor commences patient enrolment into Phase III pilot study |
| August 27 |
Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors |
| August 27 |
Photocure Announces Positive Phase II Results with Visonac for Acne |
| August 27 |
Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors |
| August 27 |
Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber |
| August 28 |
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin |
| August 28 |
The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research |
| August 28 |
National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births |
| August 28 |
New England Journal of Medicine Publishes Phase III Results of Velcade (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients |
| August 28 |
ThermoDox Liver Cancer Study Phase I Results to Be Presented at ILCA Conference 2008 |
| August 28 |
The Cypher Sirolimus-eluting Coronary Stent Outperforms the Taxus Stent in People with Diabetes |
| August 28 |
Alseres Pharmaceuticals Announces Preclinical Study Results Demonstrating that Rho Inhibitors Could Be Useful in Promoting Bone Healing |
| August 28 |
Academic Publication Highlights Method for Stabilizing the Adenosine A2a G-protein Coupled Receptor for Drug Discovery Studies |
| August 28 |
Low Levels of Brain Chemical May Lead to Obesity, NIH Study of Rare Disorder Shows |
| August 28 |
Oral Tolerability of Cysteine-Rich Protein Isolate (Immunocal) in Autism - A Pilot Study |
